PepGen (PEPG) Current Taxes (2022 - 2023)
PepGen (PEPG) posted Current Taxes of $3.4 million for Q2 2023, up 1.11% sequentially from $3.3 million in Q1 2023, and down 15.62% YoY from $4.0 million in Q2 2022.
Powered by 
Analysis
PepGen (PEPG) Current Taxes (2022 - 2023) Analysis & Trends
PepGen has reported Current Taxes for 2 years, with the latest figure at $3.4 million in Q2 2023.
- Quarterly Current Taxes fell 15.62% year-over-year to $3.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $3.4 million (down 15.62% YoY) and the FY2022 annual result came in at $2.6 million, changed N/A from the prior year.
- Current Taxes improved to $3.4 million in Q2 2023 per PEPG's latest filing, from $3.3 million in the prior quarter.
- Over five years, Current Taxes peaked at $4.3 million in Q1 2022 and troughed at $2.6 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 3.34 Mn |
| Dec 31, 2022 | 2.57 Mn |
| Sep 30, 2022 | 3.67 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 4.33 Mn |